Related Experiment Video
Updated: Feb 27, 2026
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
Quantitative analysis of the tumor suppressor dendrogenin A using liquid chromatography tandem mass spectrometry
Emmanuel Noguer1, Régis Soules2, Claude Netter3
1Affichem, Toulouse, France.
Abstract:
Dendrogenin A (DDA) was recently identified as a mammalian cholesterol metabolite that displays tumor suppressor and neurostimulating properties at low doses. In breast tumors, DDA levels were found to be decreased compared to normal tissues, evidencing a metabolic deregulation of DDA production in cancers. DDA is an amino-oxysterol that contains three protonatable nitrogen atoms. This makes it physico-chemically different from other oxysterols and it therefore requires specific analytical methods We have previously used a two-step method for the quantification of DDA in biological samples: 1) DDA purification from a Bligh and Dyer extract by RP-HPLC using a 250×4.6mm column, followed by 2) nano-electrospray ionization mass spectrometry (MS) fragmentation to analyze the HPLC fraction of interest. We report here the development a liquid chromatography tandem mass spectrometry method for the analysis of DDA and its analogues. This new method is fast (10min), resolving (peak width <4s) and has a weak carryover (<0.01%). We show that this technique efficiently separates DDA from its C17 isomer and other steroidal alkaloids from the same family establishing a proof of concept for the analysis of this family of amino-oxysterols.
Insights
Dendrogenin A (DDA), a cholesterol metabolite with tumor suppressor properties, is decreased in breast cancer. A new liquid chromatography tandem mass spectrometry method rapidly and accurately quantifies DDA and its analogues.
Area of Science:
- Biochemistry
- Analytical Chemistry
- Cancer Biology
Background:
- Dendrogenin A (DDA) is a cholesterol metabolite with identified tumor suppressor and neurostimulating properties.
- Decreased DDA levels in breast tumors suggest metabolic deregulation in cancer.
- DDA's unique amino-oxysterol structure with protonatable nitrogen atoms necessitates specialized analytical techniques.
Purpose of the Study:
- To develop a novel, rapid, and efficient analytical method for quantifying Dendrogenin A (DDA) and its analogues.
- To establish a proof of concept for analyzing amino-oxysterols using liquid chromatography tandem mass spectrometry.
Main Methods:
- Development of a liquid chromatography tandem mass spectrometry (LC-MS/MS) method.
- Optimization for speed (10 min run time), resolution (peak width <4s), and minimal carryover (<0.01%).
- Validation of the method's ability to separate DDA from its C17 isomer and related steroidal alkaloids.
Main Results:
- A new LC-MS/MS method for DDA analysis was successfully developed.
- The method demonstrates high speed, excellent resolution, and negligible carryover.
- Efficient separation of DDA from its C17 isomer and other steroidal alkaloids was achieved.
Conclusions:
- The developed LC-MS/MS method provides a fast and reliable approach for analyzing DDA and related amino-oxysterols.
- This technique facilitates further research into the role of DDA in cancer and neurological processes.
- The method establishes a foundation for the analysis of this class of steroidal compounds.
